Machine learning models can help predict which patients receiving systemic therapy for non-small lung cancer are most likely ...

Desmoid tumors can present management challenges due to their unpredictable behavior. Steven I. Robinson, MBBS, an associate professor of oncology and medical oncologist at the Ma ...

Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, today announced a research collaboration with the Rutgers Cancer Institute to evaluate the use of Haystack MRD®, a highly sensitive ...

French drugmaker Ipsen announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted ...

AstraZeneca announced that the Phase III TULIP-SC trial of SAPHNELO (anifrolumab) for treatment of people with systemic lupus erythematosus met its primary endpoint.

Akeso Inc. (9926.HK) has announced that the first patient has been dosed in its registrational Phase II study (AK130-202), evaluating AK130, a fully independently developed TIGIT/TGF-β bifunctional ...

Better diagnostics and more treatment options have modestly improved interstitial lung disease management in patients with ...

Palvella’s QTORIN rapamycin is its main value driver. Read why PVLA could pay off for patient long-term investors betting on ...

A compound comprising five agonists that together tackle weight loss, glucose reduction, insulin sensitization, and blood fat ...

Akums highlights lacosamide as a versatile and trusted therapy for epilepsy: Our Bureau, Chennai Monday, September 22, 2025, 15:45 Hrs [IST] Akums Drugs & Pharmaceuticals is highl ...

“Taking Tylenol is uh, not good,” Donald Trump said during a press conference, tying taking Tylenol during pregnancy to ...

Nano-hydroxyapatite toothpaste is a fluoride-free alternative. This is who dentists say it's best for. While the debate ...